Vincent Chan, PhD

Data Management & Sharing

People

Projects

Funding

CoProjects RFA

Data Library Analysis RFA

Data Library Development RFA

Collaborate

Back to all people

Vincent Chan, PhD

Director

About

Vincent

Vincent Chan is the Director of the ImmunoX Office of Collaborative Research, where he oversees both strategic planning and day-to-day operations. In this key leadership role, he reports directly to the ImmunoX Research Committee, ensuring seamless coordination and alignment with the organization's vision and objectives. Dr. Chan's contributions extend beyond the Office of Collaborative Research, as he also serves as the Chief Strategy Officer of ImmunoX, providing invaluable insights and guidance to the Leadership Committee. With joint appointments in the Departments of Microbiology & Immunology and Pathology, Vincent serves as an Adjunct Assistant Professor, leveraging his expertise to foster collaborative and interdisciplinary research. His academic journey culminated in a doctoral degree in Bioengineering from the University of Illinois at Urbana-Champaign.

Research & Service Areas

Projects

Immunoprofiler

Cancer

The UCSF Immunoprofiler Initiative coordinates the handling of valuable human biopsy samples taken from cancer patients, and performs a series of tests for immune composition, immune cell gene expression, and immune interaction biology. We propose that cancers are discrete forms of immunopathologies. By understanding the nature of the immune response, we will determine how to treat cancers and provide new targets for the next round of immunotherapies.

Complete

AutoImmunoprofiler

Inflammatory Bowel Disease, Lupus Cutaneous, Lupus Nephritis, Scleroderma, Sjögren’s Syndrome, Type 1 Diabetes

AutoImmunoprofiler is a consortium project with the objective to profile a range of autoimmune diseases using a combination of proteomic, transcriptomic, epigenomic, and structural analyses. Emphasis will be on freshly collected tissue samples with matched peripheral blood samples from select clinically well-annotated patients. Overall goals include to better understand the underlying mechanisms of autoimmune diseases, identify the relationship between diseased tissue and peripheral compartment, elucidate novel pathways and targets for therapeutic intervention, and to guide the selection of patients and indications for existing drugs.

Active

Collaborate with us

Your submission was sent successfully. You’ll hear from us soon. We can’t wait to collaborate.

Oops! Something went wrong while submitting the form.

Try refreshing the page and resubmitting.